Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Nicholls

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
British Journal of Clinical Pharmacology|March 1, 1997
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesG McDowell, W Coutie, C Shaw, et al.
British Journal of Biomedical Science|May 5, 2000
Familial defective apolipoprotein B-100 (R3500Q) in Northern IrelandE McClean, C A Graham, A J Ward, et al.
European Journal of Heart Failure|December 12, 2001
Bradykinin infusion in chronic cardiac failure and the effects of captoprilS M Maguire, D McAuley, C McGurk, et al.
European Heart Journal|November 1, 1993
Metabolic responses to graded exercise in chronic heart failureM Riley, N Bell, J S Elborn, et al.
European Heart Journal|October 1, 1992
The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failureM Riley, D B Northridge, E Henderson, et al.
British Journal of Biomedical Science|July 18, 2003
Genetics of the lipoprotein lipase gene and hypertriglyceridaemiaM G McDonnell, I S Young, D P Nicholls, et al.
Human Mutation|January 1, 1995
Three novel mutations in the EGF precursor homology domain of the low-density lipoprotein receptor gene in Northern Irish patients with familial hypercholesterolemiaA J Ward, M O'Kane, I Young, et al.
Clinical Science (London, England : 1979)|June 1, 1991
Resting energy expenditure in chronic cardiac failureM Riley, J S Elborn, W R McKane, et al.
Clinical Chemistry|April 29, 1998
Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failureO Hasselwander, D McMaster, D G Fogarty, et al.
European Journal of Clinical Pharmacology|January 1, 1996
A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failureJ C McElnay, T A al-Furaih, C M Hughes, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
British Journal of Clinical Pharmacology|March 1, 1997
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesG McDowell, W Coutie, C Shaw, et al.
British Journal of Biomedical Science|May 5, 2000
Familial defective apolipoprotein B-100 (R3500Q) in Northern IrelandE McClean, C A Graham, A J Ward, et al.
European Journal of Heart Failure|December 12, 2001
Bradykinin infusion in chronic cardiac failure and the effects of captoprilS M Maguire, D McAuley, C McGurk, et al.
European Heart Journal|November 1, 1993
Metabolic responses to graded exercise in chronic heart failureM Riley, N Bell, J S Elborn, et al.
European Heart Journal|October 1, 1992
The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failureM Riley, D B Northridge, E Henderson, et al.
British Journal of Biomedical Science|July 18, 2003
Genetics of the lipoprotein lipase gene and hypertriglyceridaemiaM G McDonnell, I S Young, D P Nicholls, et al.
Human Mutation|January 1, 1995
Three novel mutations in the EGF precursor homology domain of the low-density lipoprotein receptor gene in Northern Irish patients with familial hypercholesterolemiaA J Ward, M O'Kane, I Young, et al.
Clinical Science (London, England : 1979)|June 1, 1991
Resting energy expenditure in chronic cardiac failureM Riley, J S Elborn, W R McKane, et al.
Clinical Chemistry|April 29, 1998
Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failureO Hasselwander, D McMaster, D G Fogarty, et al.
European Journal of Clinical Pharmacology|January 1, 1996
A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failureJ C McElnay, T A al-Furaih, C M Hughes, et al.
Pageof 13